|Articles|May 5, 2023
Pharma 2023: Working with Patient Advocacy Groups
Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement.
Advertisement
Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how the role of patient advocacy groups to improve patient engagement, how Roche organizes their relationships and the key takeaways for industry professionals.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Director of NIH Infectious Disease Institute Steps Down
5